Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection

被引：7

作者：

Qi, Man-Li ^{[1
,2
]}

Guo, Yuan-Li ^{[3
]}

Wang, Qian-Qiu ^{[4
]}

Chen, Xiang-Sheng ^{[4
]}

Han, Jian-De ^{[5
]}

Su, Xiao-Hong ^{[6
,7
]}

Lun, Wen-Hui ^{[8
]}

Cheng, Hao ^{[9
]}

Xu, Jin-Hua ^{[10
]}

Tian, Hong-Qing ^{[11
]}

Chen, Li ^{[12
]}

Yao, Zhi-Yuan ^{[13
]}

Feng, Wen-Li ^{[14
]}

Jiang, Juan ^{[6
,7
]}

Zhou, Ping-Yu ^{[15
]}

Zou, Xian-Biao ^{[16
]}

Xu, Hong-Hui ^{[17
]}

Shi, Wei-Min ^{[18
]}

Liu, Jun ^{[19
]}

Zhu, Lin ^{[20
]}

Liu, Quan-Zhong ^{[1
,2
]}

机构：

[1] Tianjin Med Univ, Dept Dermatovenerol, Gen Hosp, Tianjin Neurol Inst,Minist Educ, Tianjin 300052, Peoples R China

[2] Tianjin City Key Lab Postneuroinjury Neurorepair, Tianjin 300052, Peoples R China

[3] Tianjin Union Med Ctr, Dept Dermatovenerol, Tianjin 300121, Peoples R China

[4] Chinese Acad Med Sci, Dept Clin Management, China CDC, Natl Ctr STD Control,Inst Dermatol, Nanjing 210042, Jiangsu, Peoples R China

[5] Sun Yat Sen Univ, Dept Dermatovenerol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China

[6] Chinese Acad Med Sci, Inst Dermatol, Nanjing 210042, Jiangsu, Peoples R China

[7] Peking Union Med Coll, Nanjing 210042, Jiangsu, Peoples R China

[8] Capital Med Univ, Dept Dermatovenerol, Beijing Ditan Hosp, Beijing 100015, Peoples R China

[9] Zhejiang Univ, Dept Dermatol, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310020, Zhejiang, Peoples R China

[10] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200040, Peoples R China

[11] Prov Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China

[12] Nanchang Univ, Affiliated Hosp 1, Dept Dermatovenerol, Nanchang 330006, Jiangxi, Peoples R China

[13] China Japan Friendship Hosp, Dept Infect Management & Dis Prevent, Beijing 100029, Peoples R China

[14] Shanxi Med Univ, Dept Dermatovenerol, Hosp 2, Taiyuan 030001, Shanxi, Peoples R China

[15] Shanghai Skin Dis Hosp, STD Inst, Shanghai 200050, Peoples R China

[16] Peoples Liberat Army Gen Hosp, Dept Dermatol, Affiliated Hosp 1, Beijing 100048, Peoples R China

[17] China Med Univ, Dept Dermatol, Hosp 1, Shenyang HOSP, Liaoning, Peoples R China

[18] Shanghai Gen Hosp, Dept Dermatovenerol, Shanghai 200080, Peoples R China

[19] 4th Peoples Hosp Qinghai Prov, Dept Dermatovenerol, Xining 810014, Qinghai, Peoples R China

[20] Southern Med Univ, Dept Dermatovenerol, Shenzhen Hosp, Shenzhen 518000, Guangdong, Peoples R China

来源：

CHINESE MEDICAL JOURNAL | 2017年 / 130卷 / 23期

关键词：

Chlamydia trachomatis; Persistent Infection; Therapy Resistant; AZITHROMYCIN; INHIBITION; GAMMA; CELLS;

D O I：

10.4103/0366-6999.219159

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chlamydia trachomatis (Ct) genital infection is the most common sexually transmitted disease (STD) in China and the US. The morbidity of Ct genital infection in China has increased from 32.48/100,000 in 2008 to 37.18/100,000 in 2015.[1] The major areas of Ct infections are concentrated in the Zhujiang Delta, Changjiang Delta, Minjiang Area, and West China. In these areas, the highest incidence of Ct infection reaches 615.99/100,000 citizens. In the US, there are 1,441,789 reported Ct, which include 627.2 females and 278.4 males per 100,000 population. It is now the most prevalent STD, with its rate increasing to 22% in males and 6% in females.[2] Ct genital infection can cause epididymitis, prostatitis, cervicitis, annexitis, infertility, and atopic pregnancy, which have been identifed as the major public health problems.

引用

页码：2852 / 2856

页数：5

共 45 条

[1] [Anonymous], 1982, Contracept Technol Update, V3, P129
[2] Lysosome repair enables host cell survival and bacterial persistence following Chlamydia trachomatis infection
Beatty, Wandy L.
[J]. CELLULAR MICROBIOLOGY, 2007, 9 (09) : 2141 - 2152
[3] REACTIVATION OF PERSISTENT CHLAMYDIA-TRACHOMATIS INFECTION IN CELL-CULTURE
BEATTY, WL
MORRISON, RP
BYRNE, GI
[J]. INFECTION AND IMMUNITY, 1995, 63 (01) : 199 - 205
[4] Azithromycin Efficacy in the Treatment of Chlamydia trachomatis Among Detained Youth
Beyda, Rebecca M.
Benjamins, Laura J.
Symanski, Elaine
Swartz, Michael
Risser, William L.
Eissa, Mona
[J]. SEXUALLY TRANSMITTED DISEASES, 2014, 41 (10) : 592 - 594
[5] Braxton J., 2014, Sexually Transmitted Disease Surveillance 2013
[6] Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract
Craig, Andrew P.
Kong, Fabian Y. S.
Yeruva, Laxmi
Hocking, Jane S.
Rank, Roger G.
Wilson, David P.
Donovan, Basil
[J]. BMC INFECTIOUS DISEASES, 2015, 15
[7] Gao Z, 2013, MED FRONTIER, V3, P297, DOI [10.3969/j.issn.2095-1752.2013.09.352, DOI 10.3969/J.ISSN.2095-1752.2013.09.352]
[8] [韩武红 Han Wuhong], 2006, [中国男科学杂志, Chinese Journal of Andrology], V20, P40
[9] Infection of human fibroblast-like synovial cells with Chlamydia trachomatis results in persistent infection and interleukin-6 production
Hanada, H
Ikeda-Dantsuji, Y
Naito, M
Nagayama, A
[J]. MICROBIAL PATHOGENESIS, 2003, 34 (02) : 57 - 63
[10] What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women?
Hathorn, Emma
Opie, Catherine
Goold, Penny
[J]. SEXUALLY TRANSMITTED INFECTIONS, 2012, 88 (05) : 352 - 354

← 1 2 3 4 5 →